Samjin Pharmaceutical Co., Ltd.(KR:005500)
₩16,940.00-3210.00 (-15.93%)
KR:005500
Samjin Pharmaceutical Co., Ltd. Revenue
₩16,940.00
At close:-3210.00 (-15.93%)
Want to see KR:005500 full AI Analyst Report?
Samjin Pharmaceutical Co., Ltd. (005500) Revenue
Samjin Pharmaceutical Co., Ltd. Revenue
Samjin Pharmaceutical Co., Ltd. had a revenue of 79.63B in the quarter ending Jun 30, 2026, with 16.98%. This bring the company's revenue in the last twelve months to 311.37B, Increased 1.64%. In the fiscal year ending Dec 31, 2025, Samjin Pharmaceutical Co., Ltd. had annual revenue of 309.13B with 0.25% growth.
- Revenue (ttm)
- 311.37B
- Revenue Growth
- 0.28%
- P/S Ratio
- 0.76
- Revenue/Employee
- KRW 377,452,419
- Employees
- 819
- Market Cap
- KRW 236.21B
Revenue Chart
Samjin Pharmaceutical Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 309.13B | 783.60M | 0.25% |
| Dec 31, 2024 | 308.35B | 16.22B | 5.55% |
| Dec 31, 2023 | 292.13B | 18.10B | 6.60% |
| Dec 31, 2022 | 274.03B | 23.96B | 9.58% |
| Dec 31, 2021 | 250.07B | 14.91B | 6.34% |
| Dec 31, 2020 | 235.16B | -6.76B | -2.79% |
| Dec 31, 2019 | 241.93B | -18.09B | -6.96% |
| Dec 31, 2018 | 260.02B | 14.74B | 6.01% |
| Dec 31, 2017 | 245.27B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

